A citation-based method for searching scientific literature

Gavin Chapman, Duncan B Sparrow, Elisabeth Kremmer, Sally L Dunwoodie. Hum Mol Genet 2011
Times Cited: 118







List of co-cited articles
1185 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
Laura R Saunders, Alexander J Bankovich, Wade C Anderson, Monette A Aujay, Sheila Bheddah, KristenAnn Black, Radhika Desai, Paul A Escarpe, Johannes Hampl, Amy Laysang,[...]. Sci Transl Med 2015
321
48

The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands.
Ena Ladi, James T Nichols, Weihong Ge, Alison Miyamoto, Christine Yao, Liang-Tung Yang, Jim Boulter, Yi E Sun, Chris Kintner, Gerry Weinmaster. J Cell Biol 2005
202
37

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Charles M Rudin, M Catherine Pietanza, Todd M Bauer, Neal Ready, Daniel Morgensztern, Bonnie S Glisson, Lauren A Byers, Melissa L Johnson, Howard A Burris, Francisco Robert,[...]. Lancet Oncol 2017
298
37

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo.
Insa Geffers, Katrin Serth, Gavin Chapman, Robert Jaekel, Karin Schuster-Gossler, Ralf Cordes, Duncan B Sparrow, Elisabeth Kremmer, Sally L Dunwoodie, Thomas Klein,[...]. J Cell Biol 2007
110
28

Comprehensive genomic profiles of small cell lung cancer.
Julie George, Jing Shan Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lu, Lynnette Fernández-Cuesta, Graziella Bosco,[...]. Nature 2015
21

Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
Muthusamy Kunnimalaiyaan, Herbert Chen. Oncologist 2007
143
18

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.
Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Davila, Neal Ready, Christine L Hann, Bonnie S Glisson, Anna F Farago, Afshin Dowlati, Charles M Rudin,[...]. Clin Cancer Res 2019
136
18


Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis.
M P Bulman, K Kusumi, T M Frayling, C McKeown, C Garrett, E S Lander, R Krumlauf, A T Hattersley, S Ellard, P D Turnpenny. Nat Genet 2000
283
15

O-fucosylation of DLL3 is required for its function during somitogenesis.
Katrin Serth, Karin Schuster-Gossler, Elisabeth Kremmer, Birte Hansen, Britta Marohn-Köhn, Achim Gossler. PLoS One 2015
37
40

Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer.
Kentaro Tanaka, Kumiko Isse, Tomomichi Fujihira, Mitsuhiro Takenoyama, Laura Saunders, Sheila Bheddah, Yoichi Nakanishi, Isamu Okamoto. Lung Cancer 2018
52
28

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Leora Horn, Aaron S Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J Hochmair, Florian Huemer, György Losonczy, Melissa L Johnson, Makoto Nishio,[...]. N Engl J Med 2018
14


Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Scott J Antonia, José A López-Martin, Johanna Bendell, Patrick A Ott, Matthew Taylor, Joseph Paul Eder, Dirk Jäger, M Catherine Pietanza, Dung T Le, Filippo de Braud,[...]. Lancet Oncol 2016
792
12

Mechanism and significance of cis-inhibition in Notch signalling.
David del Álamo, Hervé Rouault, François Schweisguth. Curr Biol 2011
171
10

Structural basis for autoinhibition of Notch.
Wendy R Gordon, Didem Vardar-Ulu, Gavin Histen, Cheryll Sanchez-Irizarry, Jon C Aster, Stephen C Blacklow. Nat Struct Mol Biol 2007
238
10


Ascl1 and Neurog2 form novel complexes and regulate Delta-like3 (Dll3) expression in the neural tube.
R Michael Henke, David M Meredith, Mark D Borromeo, Trisha K Savage, Jane E Johnson. Dev Biol 2009
60
16

Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.
Tianyun Jiang, Brendan J Collins, Ning Jin, David N Watkins, Malcolm V Brock, William Matsui, Barry D Nelkin, Douglas W Ball. Cancer Res 2009
130
10

Structural biology. Structural basis for Notch1 engagement of Delta-like 4.
Vincent C Luca, Kevin M Jude, Nathan W Pierce, Maxence V Nachury, Suzanne Fischer, K Christopher Garcia. Science 2015
158
10

Fringe proteins modulate Notch-ligand cis and trans interactions to specify signaling states.
Lauren LeBon, Tom V Lee, David Sprinzak, Hamed Jafar-Nejad, Michael B Elowitz. Elife 2014
85
11

Delta-like 3 is silenced by methylation and induces apoptosis in human hepatocellular carcinoma.
Kentaro Maemura, Hirohide Yoshikawa, Kazutake Yokoyama, Teruo Ueno, Hitomi Kurose, Kazuhisa Uchiyama, Yoshinori Otsuki. Int J Oncol 2013
22
45

ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.
Mark D Borromeo, Trisha K Savage, Rahul K Kollipara, Min He, Alexander Augustyn, Jihan K Osborne, Luc Girard, John D Minna, Adi F Gazdar, Melanie H Cobb,[...]. Cell Rep 2016
194
10

Notch signalling in context.
Sarah J Bray. Nat Rev Mol Cell Biol 2016
512
10

Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer.
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, Sean D Carlin, Alessandra Piersigilli, Alexander J Bankovich, Eric E Gardner, Omar Hamdy, Kumiko Isse, Sheila Bheddah,[...]. Cancer Res 2017
48
20

DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.
Megumi Furuta, Hajime Kikuchi, Tetsuaki Shoji, Yuta Takashima, Eiki Kikuchi, Junko Kikuchi, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Jun Sakakibara-Konishi. Cancer Sci 2019
32
31

Unravelling the biology of SCLC: implications for therapy.
Joshua K Sabari, Benjamin H Lok, James H Laird, John T Poirier, Charles M Rudin. Nat Rev Clin Oncol 2017
219
10

Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma.
Marissa Spino, Sylvia C Kurz, Luis Chiriboga, Jonathan Serrano, Briana Zeck, Namita Sen, Seema Patel, Guomiao Shen, Varshini Vasudevaraja, Aristotelis Tsirigos,[...]. Clin Cancer Res 2019
32
31

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
Loredana Puca, Katie Gavyert, Verena Sailer, Vincenza Conteduca, Etienne Dardenne, Michael Sigouros, Kumiko Isse, Megan Kearney, Aram Vosoughi, Luisa Fernandez,[...]. Sci Transl Med 2019
65
15

Notch signalling: a simple pathway becomes complex.
Sarah J Bray. Nat Rev Mol Cell Biol 2006
9

Notch signaling: cell fate control and signal integration in development.
S Artavanis-Tsakonas, M D Rand, R J Lake. Science 1999
9

ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Alexander Augustyn, Mark Borromeo, Tao Wang, Junya Fujimoto, Chunli Shao, Patrick D Dospoy, Victoria Lee, Christopher Tan, James P Sullivan, Jill E Larsen,[...]. Proc Natl Acad Sci U S A 2014
138
9

Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of Notch.
Wendy R Gordon, Brandon Zimmerman, Li He, Laura J Miles, Jiuhong Huang, Kittichoat Tiyanont, Debbie G McArthur, Jon C Aster, Norbert Perrimon, Joseph J Loparo,[...]. Dev Cell 2015
174
9

Cis-interactions between Notch and Delta generate mutually exclusive signalling states.
David Sprinzak, Amit Lakhanpal, Lauren Lebon, Leah A Santat, Michelle E Fontes, Graham A Anderson, Jordi Garcia-Ojalvo, Michael B Elowitz. Nature 2010
391
9

DLL3: an emerging target in small cell lung cancer.
Dwight H Owen, Michael J Giffin, Julie M Bailis, Marie-Anne Damiette Smit, David P Carbone, Kai He. J Hematol Oncol 2019
71
12

The Notch1 receptor is cleaved constitutively by a furin-like convertase.
F Logeat, C Bessia, C Brou, O LeBail, S Jarriault, N G Seidah, A Israël. Proc Natl Acad Sci U S A 1998
549
8

Lfng regulates the synchronized oscillation of the mouse segmentation clock via trans-repression of Notch signalling.
Yusuke Okubo, Takeshi Sugawara, Natsumi Abe-Koduka, Jun Kanno, Akatsuki Kimura, Yumiko Saga. Nat Commun 2012
66
12


Therapeutic antibody targeting of individual Notch receptors.
Yan Wu, Carol Cain-Hom, Lisa Choy, Thijs J Hagenbeek, Gladys P de Leon, Yongmei Chen, David Finkle, Rayna Venook, Xiumin Wu, John Ridgway,[...]. Nature 2010
525
8

Notch inhibitors for cancer treatment.
Ingrid Espinoza, Lucio Miele. Pharmacol Ther 2013
205
8

The many facets of Notch ligands.
B D'Souza, A Miyamoto, G Weinmaster. Oncogene 2008
319
8

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
Charles M Rudin, Steffen Durinck, Eric W Stawiski, John T Poirier, Zora Modrusan, David S Shames, Emily A Bergbower, Yinghui Guan, James Shin, Joseph Guillory,[...]. Nat Genet 2012
676
8

Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin.
Laurence Meloty-Kapella, Bhupinder Shergill, Jane Kuon, Elliot Botvinick, Gerry Weinmaster. Dev Cell 2012
153
8

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
Lauren Averett Byers, Jing Wang, Monique B Nilsson, Junya Fujimoto, Pierre Saintigny, John Yordy, Uma Giri, Michael Peyton, You Hong Fan, Lixia Diao,[...]. Cancer Discov 2012
332
8

Therapeutic modulation of Notch signalling--are we there yet?
Emma R Andersson, Urban Lendahl. Nat Rev Drug Discov 2014
324
8

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, Afshin Dowlati, Christine L Hann, Alberto Chiappori, Taofeek K Owonikoko, Kaitlin M Woo, Robert J Cardnell, Junya Fujimoto,[...]. J Clin Oncol 2018
185
8

Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype.
D B Sparrow, G Chapman, M A Wouters, N V Whittock, S Ellard, D Fatkin, P D Turnpenny, K Kusumi, D Sillence, S L Dunwoodie. Am J Hum Genet 2006
164
7

Ligand-induced signaling in the absence of furin processing of Notch1.
G Bush, G diSibio, A Miyamoto, J B Denault, R Leduc, G Weinmaster. Dev Biol 2001
105
7

A cell autonomous role for the Notch ligand Delta-like 3 in αβ T-cell development.
Gerard F Hoyne, Gavin Chapman, Yovina Sontani, Sharon E Pursglove, Sally L Dunwoodie. Immunol Cell Biol 2011
20
35

A mechanism for gene-environment interaction in the etiology of congenital scoliosis.
Duncan B Sparrow, Gavin Chapman, Allanceson J Smith, Muhammad Z Mattar, Joelene A Major, Victoria C O'Reilly, Yumiko Saga, Elaine H Zackai, John P Dormans, Benjamin A Alman,[...]. Cell 2012
134
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.